Medipharm Signs Danish White Label Agreement

Medipharm Labs (TSX: LABS) continues to expand its international presence, this morning announcing that it has signed a white label supply agreement with DanCann Pharma A/S. The arrangement will see Medipharm export its white labeled product from its facilities in both Canada and Australia to that of Denmark.

DanCann Pharma, established in 2018 following regulatory changes in the country of Denmark related to the status of medical cannabis in the country, is focused on what it refers to as therapeutic cannabinoids. The company manufacturers and imports prescription and over the counter pharmaceuticals for pain patients that are covered until the pilot program for medical cannabis in Denmark.

While Medipharm was quick to press release the new agreement, details provided by the company are relatively slim. What is known about the contract is that it is for a two year period, during which time Medipharm will “supply a full range of specially formulated CBD and THC products.” These products will be white labelled for distribution by DanCann.

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

It’s unclear if there are any contractual minimums or maximums associated with the agreement, or the significance of the contract in terms of dollars.

Medipharm Labs last traded at $0.80 on the TSX.


.Information for this briefing was found via Sedar and Medipharm Labs. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Epic Gold Outlines 150,700 Indicated Ounces at 2.26 G/T in Updated Benoist Resource

Related News

Is 2020 The Year Cannabis Extractors Come Down With The Cronos Virus?

Our sharp-eyed editor Jay pointed out last week that cannabis cultivator Cronos Group Inc. (TSX:...

Sunday, March 15, 2020, 01:23:04 PM

Medipharm Labs Receives Australian Drug Import License

Medipharm Labs (TSX: LABS) announced this morning that the firm has received an importation license...

Friday, January 31, 2020, 09:04:16 AM

Medipharm Labs Revenues Crater 64.5% Quarter Over Quarter To $4.9 Million

It appears that not all operators are able to successfully perform under the changing market...

Monday, November 16, 2020, 08:01:12 AM

Will The Medipharm Labs Statement Of Claim Cause Further Issue For Hexo Corp?

It’s been revealed today by that of BNN Bloomberg that Medipharm Labs’ (TSX: LABS) statement...

Monday, January 27, 2020, 08:30:12 PM

Medipharm Labs Sees CEO Pat McCutcheon Step Down From Role, Remain As Chairman

Medipharm Labs (TSX: LABS) this morning announced drastic changes to its leadership role, with the...

Thursday, December 10, 2020, 07:38:42 AM